First Time Loading...

Ergo Science Corp
OTC:ERGN

Watchlist Manager
Ergo Science Corp Logo
Ergo Science Corp
OTC:ERGN
Watchlist
Price: 10 800 USD
Updated: Apr 16, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

25.6m
-29%
Revenue
Growth Rates:
1 Year
-34%
3 Years
+51%
5 Years
-
7 Years
-
10 Years
-
-5.3m
-5%
Operating Income
Growth Rates:
1 Year
+18%
3 Years
-4 329%
5 Years
-199%
7 Years
-102%
10 Years
+74%
-4.3m
+43%
Net Income
Growth Rates:
1 Year
+29%
3 Years
-
5 Years
-322%
7 Years
-400%
10 Years
+77%

Earnings Waterfall
Ergo Science Corp

Revenue
25.6m USD
Cost of Revenue
-17.5m USD
Gross Profit
8.1m USD
Operating Expenses
-13.4m USD
Operating Income
-5.3m USD
Other Expenses
1m USD
Net Income
-4.3m USD

Income Statement
Ergo Science Corp

Rotate your device to view
Income Statement
Currency: USD
Jun-1997 Sep-1997 Dec-1997 Mar-1998 Jun-1998 Sep-1998 Dec-1998 Mar-1999 Jun-1999 Sep-1999 Dec-1999 Mar-2000 Jun-2000 Sep-2000 Dec-2000 Mar-2001 Jun-2001 Sep-2001 Dec-2001 Mar-2002 Jun-2002 Sep-2002 Dec-2002 Mar-2003 Jun-2003 Sep-2003 Dec-2003 Mar-2004 Jun-2004 Sep-2004 Dec-2004 Mar-2005 Jun-2005 Sep-2005 Dec-2005 Mar-2006 Jun-2006 Sep-2006 Dec-2006 Jun-2007
Revenue
Revenue
0
N/A
0
N/A
0
N/A
15
N/A
17
+13%
18
+5%
19
+5%
4
-81%
2
-54%
1
-50%
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
8
N/A
17
+120%
27
+61%
27
N/A
26
-4%
25
-3%
26
+3%
35
+35%
34
-4%
39
+15%
37
-4%
36
-3%
26
-29%
Gross Profit
Cost of Revenue
0
0
0
(2)
(2)
(2)
(2)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(6)
(12)
(21)
0
(20)
(20)
(20)
(25)
(23)
(28)
(27)
(26)
(17)
Gross Profit
0
N/A
0
N/A
0
N/A
13
N/A
15
+15%
16
+6%
16
+5%
4
-78%
2
-54%
1
-50%
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
1
N/A
4
+200%
7
+46%
0
N/A
6
N/A
5
-10%
6
+23%
10
+63%
10
+0%
11
+6%
11
-4%
10
-7%
8
-18%
Operating Income
Operating Expenses
(20)
(19)
(20)
(21)
(21)
(21)
(22)
(19)
(15)
(12)
(6)
(4)
(3)
(2)
(2)
(2)
(2)
(3)
(3)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(5)
(6)
(27)
(7)
(8)
(9)
(12)
(15)
(17)
(18)
(15)
(13)
Selling, General & Administrative
(8)
(7)
(7)
(7)
(7)
(7)
(8)
(7)
(6)
(5)
(4)
(3)
(2)
(2)
(2)
(2)
(2)
(3)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(5)
(6)
(6)
(6)
(7)
(8)
(11)
(11)
(14)
(14)
(15)
(10)
Research & Development
(12)
(13)
(13)
(14)
(14)
(14)
(15)
(12)
(9)
(7)
(2)
(1)
(0)
0
0
0
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
Other Operating Expenses
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(21)
0
0
0
0
(3)
(3)
(3)
0
(3)
Operating Income
(20)
N/A
(19)
+4%
(20)
-5%
(8)
+61%
(7)
+17%
(5)
+22%
(6)
-11%
(15)
-166%
(13)
+12%
(11)
+15%
(6)
+47%
(4)
+36%
(3)
+30%
(2)
+41%
(2)
-3%
(2)
-8%
(2)
-22%
(3)
-29%
(3)
+7%
(2)
+11%
(2)
+20%
(1)
+27%
(1)
+22%
(1)
-2%
(1)
N/A
(1)
-13%
(1)
+23%
(1)
-30%
(0)
+90%
1
N/A
0
-65%
(1)
N/A
(2)
-147%
(2)
+10%
(1)
+44%
(4)
-246%
(6)
-50%
(7)
-12%
(5)
+30%
(5)
-5%
Pre-Tax Income
Interest Income Expense
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Non-Reccuring Items
(0)
(0)
0
0
(3)
(3)
(3)
(3)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
0
0
0
0
(3)
0
0
0
(3)
0
Gain/Loss on Disposition of Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
0
0
0
0
0
0
0
0
6
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Other Income
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
6
5
0
0
0
0
0
0
0
0
0
0
Pre-Tax Income
(18)
N/A
(18)
+5%
(19)
-5%
(6)
+66%
(7)
-16%
(6)
+21%
(6)
-8%
(16)
-147%
(11)
+27%
(10)
+17%
(4)
+55%
(2)
+50%
(1)
+59%
0
N/A
0
+3%
0
-52%
(0)
N/A
(1)
-208%
(1)
-7%
(1)
N/A
(1)
+18%
(1)
+29%
(1)
+17%
(1)
-8%
(1)
-6%
(1)
-13%
5
N/A
5
-7%
6
+22%
6
+12%
1
-91%
(1)
N/A
(2)
-219%
(2)
+11%
(4)
-112%
(4)
+1%
(6)
-50%
(7)
-12%
(8)
-11%
(5)
+39%
Net Income
Tax Provision
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
(0)
(0)
(0)
(0)
(0)
(0)
0
(0)
0
0
0
0
Income from Continuing Operations
(18)
(18)
(19)
(6)
(7)
(6)
(6)
(16)
(11)
(10)
(4)
(2)
(1)
0
0
0
(0)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
5
5
5
6
0
(1)
(2)
(2)
(4)
(4)
(6)
(7)
(8)
(4)
Net Income (Common)
(18)
N/A
(18)
+5%
(19)
-5%
(6)
+66%
(7)
-16%
(6)
+21%
(6)
-8%
(16)
-147%
(11)
+27%
(10)
+17%
(4)
+55%
(2)
+50%
(1)
+59%
0
N/A
0
+3%
0
-52%
(0)
N/A
(1)
-208%
(1)
-7%
(1)
N/A
(1)
+18%
(1)
+29%
(1)
+17%
(1)
-8%
(1)
-6%
(1)
-13%
5
N/A
5
-4%
5
+15%
6
+10%
0
-95%
(1)
N/A
(2)
-224%
(2)
+16%
(4)
-95%
(4)
-7%
(6)
-43%
(7)
-10%
(8)
-12%
(4)
+43%
EPS (Diluted)
-29 769.57
N/A
-27 484.25
+8%
-28 766.76
-5%
-11 356.44
+61%
-12 300.72
-8%
-9 653.47
+22%
-9 808.26
-2%
-22 532.5
-130%
-16 723.74
+26%
-14 068.8
+16%
-6 678.4
+53%
-3 703.75
+45%
-1 941.6
+48%
-309.96
+84%
-305.71
+1%
-351.65
-15%
-922.27
-162%
-1 826.69
-98%
-1 748.36
+4%
-1 749.76
0%
-1 421.07
+19%
-997.27
+30%
-819.63
+18%
-893.76
-9%
-953.9
-7%
-1 126.9
-18%
8 440.83
N/A
8 068.32
-4%
9 240.1
+15%
10 120.6
+10%
493.64
-95%
-1 305.51
N/A
-4 188.27
-221%
-3 532.35
+16%
-6 867.48
-94%
-7 355.17
-7%
-10 484.48
-43%
-11 568.97
-10%
-12 962.07
-12%
-7 415.52
+43%

See Also

Summary
ERGN intrinsic value, competitors valuation, and company profile.
DCF Valuation
ERGN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ERGN stock valuation using valuation multiples.
Wall Street Estimates
ERGN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ERGN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 128,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.